Cargando…

Stool vs. Serum Hepatitis B Virus DNA in Patients with Chronic Hepatitis B

BACKGROUND: Serum hepatitis B virus (HBV) DNA and hepatitis B e antigen (HBeAg) liver function in patients with chronic hepatitis B (CHB) are significantly associated. A comparison of clinical significance of fecal HBV DNA and serum HBV DNA has not yet been reported. MATERIAL/METHODS: Stool and seru...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zheng, Ji-shun, Chen, Meng-meng, Yang, Hai-fei, Zhou, Xiang-tian, Liu, Yan-yan, Li, Jia-bin
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	International Scientific Literature, Inc. 2015
Materias:	Clinical Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4677737/ https://www.ncbi.nlm.nih.gov/pubmed/26645150 http://dx.doi.org/10.12659/MSM.896243

Ejemplares similares

Correlations between serum hepatitis B core-related antigen and hepatitis B surface antigen in patients with hepatitis B cirrhosis and a hepatitis B virus-DNA-negative status: a retrospective study
por: Xu, Baiguo, et al.
Publicado: (2022)

Serum apolipoprotein C3 levels are negatively associated with hepatitis B virus DNA in HBeAg-negative chronic hepatitis B patients
por: Cui, Yu, et al.
Publicado: (2019)

Serum lipid alterations identified in chronic hepatitis B, hepatitis B virus-associated cirrhosis and carcinoma patients
por: Wu, Tao, et al.
Publicado: (2017)

Elevated soluble 4-1BB is associated with serum markers of hepatitis B virus in patients with chronic hepatitis B
por: Zhan, Meng-Ru, et al.
Publicado: (2021)

Effects of Entecavir on Hepatitis B Virus Covalently Closed Circular DNA in Hepatitis B e Antigen-Positive Patients with Hepatitis B
por: Shi, Ming, et al.
Publicado: (2015)

Hepatitis B Virus RNA Detection and a Mindful Use of Serum Hepatitis B Virus DNA and Hepatitis B Surface Antigen Measures in Clinical Practice
por: Brunetto, Maurizia R.
Publicado: (2020)

Phase IIb trial of in vivo electroporation mediated dual-plasmid hepatitis B virus DNA vaccine in chronic hepatitis B patients under lamivudine therapy
por: Yang, Fu-Qiang, et al.
Publicado: (2017)

Serum Galectin-3 Levels in Children with Chronic Hepatitis B Infection and Inactive Hepatitis B Carriers
por: Uluca, Ünal, et al.
Publicado: (2015)

Hepatitis D virus dual-infection among Chinese hepatitis B patient related to hepatitis B surface antigen, hepatitis B virus DNA and age
por: Zi, Jun, et al.
Publicado: (2023)

Ultrasensitive detection of serum hepatitis B virus by coupling ultrafiltration DNA extraction with real-time PCR
por: Wu, Bin, et al.
Publicado: (2017)

Telbivudine vs tenofovir in hepatitis B e antigen-negative chronic hepatitis B patients: OPTIMA roadmap study
por: Krastev, Zahari, et al.
Publicado: (2016)

Serum hepatitis B core-related antigen is a satisfactory surrogate marker of intrahepatic covalently closed circular DNA in chronic hepatitis B
por: Chen, En-Qiang, et al.
Publicado: (2017)

Prevalence and clinical characteristics of hepatitis B surface antigen-negative/hepatitis B core antibody-positive patients with detectable serum hepatitis B virus DNA
por: Cai, Jingyao, et al.
Publicado: (2022)

Interferon and lamivudine vs. interferon for hepatitis B e antigen-positive hepatitis B treatment: meta-analysis of randomized controlled trials
por: Rudin, Dan, et al.
Publicado: (2007)

Detection of Hepatitis B virus in serum and liver of chickens
por: Tian, Jijing, et al.
Publicado: (2012)

Development and Evaluation of a Molecular Hepatitis A Virus Assay for Serum and Stool Specimens
por: Kozak, Robert A., et al.
Publicado: (2022)

Serum hepatitis B core antibody titer use in screening for significant fibrosis in treatment-naïve patients with chronic hepatitis B
por: Li, Min-ran, et al.
Publicado: (2016)

The hepatitis B virus reactivation after transarterial chemoembolization in Chinese hepatocellular carcinoma patients with low serum hepatitis B virus DNA level
por: Shao, Wenbo, et al.
Publicado: (2015)

Effectiveness of Tenofovir Alafenamide in Chronic Hepatitis B Patients with Normal Alanine Aminotransferase and Positive Hepatitis B Virus DNA
por: Gao, Wen-Kang, et al.
Publicado: (2022)

Early hepatitis B viral DNA clearance predicts treatment response at week 96
por: Fu, Xiao-Yu, et al.
Publicado: (2017)

Hepatitis B serological markers and plasma DNA concentrations
por: Price, Huw, et al.
Publicado: (2017)

Characterization of the hepatitis B virus DNA detected in urine of chronic hepatitis B patients
por: Jain, Surbhi, et al.
Publicado: (2018)

Value of anti-hepatitis B virus in serum tested by enzyme linked immunosorbent assay 3 in diagnosis of hepatitis B: A protocol for systemic review and meta analysis
por: Fei-fei, Shen, et al.
Publicado: (2021)

Clinical Characteristics and Correlation Analysis of Subjects with Chronic Hepatitis B Virus (HBV) Infection and Sustained Low Levels of Hepatitis B Surface Antigen (HBsAg)
por: Cheng, Jun, et al.
Publicado: (2018)

Usefulness of Contrast-Enhanced Ultrasonography for Predicting Esophageal Varices in Patients with Hepatitis B Virus (HBV)-Related Cirrhosis
por: Li, Jun, et al.
Publicado: (2017)

Hepatitis B virus associated localized laryngeal amyloidosis
por: Sakthivel, Pirabu, et al.
Publicado: (2020)

Performance of common imaging techniques vs serum biomarkers in assessing fibrosis in patients with chronic hepatitis B: A systematic review and meta-analysis
por: Xu, Xue-Ying, et al.
Publicado: (2019)

Effects of viral load on tenofovir vs. entecavir efficacy in recurrence prevention of hepatitis B virus-related hepatocellular carcinoma
por: Qi, Weili, et al.
Publicado: (2023)

Biogenesis and molecular characteristics of serum hepatitis B virus RNA
por: Shen, Sheng, et al.
Publicado: (2020)

DNA Engineering and Hepatitis B Virus Replication
por: Gan, Chun-yang, et al.
Publicado: (2021)

Robust in vitro assay for analyzing the neutralization activity of serum specimens against hepatitis B virus
por: Zhang, Ya-Li, et al.
Publicado: (2019)

Low Serum Hepatitis B Surface Antigen Level Predicts Compensated Cirrhosis Caused by Chronic Hepatitis B in HBeAg Positive Patients in East China
por: Jia, Wen, et al.
Publicado: (2015)

Postoperative hepatitis B virus reactivation in hepatitis B virus-related hepatocellular carcinoma patients with hepatitis B virus DNA levels <500 copies/mL
por: Xie, Zhi-Bo, et al.
Publicado: (2016)

Hepatitis C virus and hepatitis B virus in patients with schizophrenia
por: Chang, Chun-Hung, et al.
Publicado: (2021)

Positive association between serum apolipoprotein M levels and hepatitis B virus DNA load in HBeAg-negative chronic hepatitis B
por: Shen, Ting, et al.
Publicado: (2016)

Performance of Hepatitis B Core-Related Antigen Versus Hepatitis B Surface Antigen and Hepatitis B Virus DNA in Predicting HBeAg-positive and HBeAg-negative Chronic Hepatitis
por: Zhang, Zhan-qing, et al.
Publicado: (2019)

Interference of Apoptosis by Hepatitis B Virus
por: Lin, Shaoli, et al.
Publicado: (2017)

Serum hepatitis B core-related antigen as a surrogate marker of hepatitis B e antigen seroconversion in chronic hepatitis B
por: Chi, Xiu-Mei, et al.
Publicado: (2021)

Serum hepatitis B core antibody as a biomarker of hepatic inflammation in chronic hepatitis B patients with normal alanine aminotransferase
por: Zhou, Jiyuan, et al.
Publicado: (2017)

Capabilities of hepatitis B surface antigen are divergent from hepatitis B virus DNA in delimiting natural history phases of chronic hepatitis B virus infection
por: Zhang, Zhanqing, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_22dq7ops3c7hhc1r574fam1mb3